Sarah Alexander serves as Executive at NEWLINK GENETICS CORP, where they oversee executive responsibilities. Since joining the company, Sarah Alexander has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 16, 2011 involved exercising options for 542 shares valued at $0.
Sarah Alexander currently holds 5,833 shares of NEWLINK GENETICS CORP (NLNK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sarah Alexander has been a net neutral trader of NLNK stock. They have purchased $0 and sold $0 worth of shares.
Sarah Alexander's most recent insider trade was on Nov 16, 2011, when they sold 542 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |